Compare ARK Genomic Revolution ETF (ARKG) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares 10 20 Year Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares 10 20 Year Treasury Bond ETF trades at $98.5. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | TLH | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $105.36 |
52-Week Low | $23.09 | $97.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TLH trades at $98.50, down 0.04% on the day, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The stock faces resistance at $99 and finds support at $98. Recent dividends of $0.41 and $0.36 were declared for H1-26 and H2-26 respectively, providing income to shareholders amid current market volatility.
The outlook remains cautious due to bearish technical signals and broader market uncertainty. Key risks include macroeconomic pressures from potential Fed rate hikes and geopolitical tensions affecting energy markets. Investors should monitor earnings reports for fundamental strength validation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
